ID

16588

Beschreibung

Effects of Growth Hormone on the Nitric Oxide Pathway; ODM derived from: https://clinicaltrials.gov/show/NCT00470002

Link

https://clinicaltrials.gov/show/NCT00470002

Stichworte

  1. 25.07.16 25.07.16 -
Hochgeladen am

25. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Cardiovascular Disease NCT00470002

Eligibility Cardiovascular Disease NCT00470002

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
healthy male subjects without recent severe diseases
Beschreibung

Gender | Healthy | Disease Severe

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C3898900
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0205082
age 50 yrs or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
body mass index at or below 30 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
insulin-like growth factor-1 level below 200 ng/ml
Beschreibung

Insulin-Like Growth Factor I Level

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021665
UMLS CUI [1,2]
C0441889
evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
subjects that are willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
Beschreibung

Study Protocol Compliance behavior

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C1321605
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of any severe hepatic, renal, cardiac, endocrine, metabolic, or malignant diseases
Beschreibung

Liver diseases Severe | Kidney Diseases | Heart Diseases | Endocrine System Diseases | Metabolic Diseases | Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0018799
UMLS CUI [4]
C0014130
UMLS CUI [5]
C0025517
UMLS CUI [6]
C0006826
requirement for medical drug treatment
Beschreibung

Pharmacotherapy Requirement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C1514873
growth hormone treatment during the last 12 months
Beschreibung

growth hormone treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0744483
drug dependence, alcohol or nicotine abuse
Beschreibung

Drug Dependence | Alcohol abuse | Nicotine abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C1510472
UMLS CUI [2]
C0085762
UMLS CUI [3]
C2363943
other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results and, in the judgement of the investigator, would make the subject inappropriate for entry into this study.
Beschreibung

Comorbidity Study Subject Participation Status Limited | Laboratory test result abnormal Study Subject Participation Status Limited | Comorbidity Interferes with research results | Laboratory test result abnormal Interferes with research results

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0439801
UMLS CUI [2,1]
C0438215
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C0439801
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0683954
UMLS CUI [4,1]
C0438215
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0683954

Ähnliche Modelle

Eligibility Cardiovascular Disease NCT00470002

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Healthy | Disease Severe
Item
healthy male subjects without recent severe diseases
boolean
C0079399 (UMLS CUI [1])
C3898900 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Age
Item
age 50 yrs or older
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index at or below 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Insulin-Like Growth Factor I Level
Item
insulin-like growth factor-1 level below 200 ng/ml
boolean
C0021665 (UMLS CUI [1,1])
C0441889 (UMLS CUI [1,2])
Informed Consent
Item
evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial
boolean
C0021430 (UMLS CUI [1])
Study Protocol Compliance behavior
Item
subjects that are willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
boolean
C2348563 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Liver diseases Severe | Kidney Diseases | Heart Diseases | Endocrine System Diseases | Metabolic Diseases | Malignant Neoplasms
Item
history of any severe hepatic, renal, cardiac, endocrine, metabolic, or malignant diseases
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
C0025517 (UMLS CUI [5])
C0006826 (UMLS CUI [6])
Pharmacotherapy Requirement
Item
requirement for medical drug treatment
boolean
C0013216 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
growth hormone treatment
Item
growth hormone treatment during the last 12 months
boolean
C0744483 (UMLS CUI [1])
Drug Dependence | Alcohol abuse | Nicotine abuse
Item
drug dependence, alcohol or nicotine abuse
boolean
C1510472 (UMLS CUI [1])
C0085762 (UMLS CUI [2])
C2363943 (UMLS CUI [3])
Comorbidity Study Subject Participation Status Limited | Laboratory test result abnormal Study Subject Participation Status Limited | Comorbidity Interferes with research results | Laboratory test result abnormal Interferes with research results
Item
other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results and, in the judgement of the investigator, would make the subject inappropriate for entry into this study.
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0438215 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C0438215 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video